Buy & Sell BIO-TECHNE Corp (TECH) – BIO-TECHNE Corp Price Today
Key Stats
- $8.31BMarket Cap
- HealthSector
- -31.61%3M Drawdown
- $8.49BEnterprise Value
- 0.6%Dividend Yield
- 66 daysTypical Hold Time
BIO-TECHNE Corp (TECH) is currently valued at a market capitalization of $8.31B, with an enterprise value of $8.49B. Over the past 52 weeks, BIO-TECHNE Corp has traded between a low of $46.66 and a high of $71.38, highlighting its annual price range. Over the past three months, BIO-TECHNE Corp has recorded a drawdown of -31.61%, reflecting recent price volatility. BIO-TECHNE Corp offers a dividend yield of 0.6%, with the most recent dividend of $0.08 paid on 13 Feb 26. On average, investors hold BIO-TECHNE Corp for approximately 66 days, indicating typical investor behavior on the platform.
About BIO-TECHNE Corp
Based in Minnesota, Bio-Techne is a life sciences manufacturer supplying consumables and instruments for the pharma, biotech, academic, and diagnostic markets. The company reports in two segments, protein sciences (75% of revenue), and diagnostics and genomics (25%). The protein-focused segment makes equipment and associated consumables for protein characterization and analysis and sells antibodies for research and clinical purposes. In diagnostics, Bio-Techne provides controls and calibrators for diagnostic manufacturers and has a portfolio of diagnostic oncology assays. The United States accounts for about 55% of revenue, and the firm also has operations in EMEA (20% of sales), the U.K. (5%), and APAC (15%), with the rest of the world accounting for the remaining 5%.
